Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Early Detection Research Network (EDRN)

Visit the EDRN Website

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name PI Organization Title Grant Number Program Official
Anderson, Karen Sue

Arizona State University-Tempe Campus
United States

 Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-03 Wendy Wang, Ph.D., M.Sc.
Bast, Robert C

University Of Tx Md Anderson Can Ctr
United States

 MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm 5U01CA200462-08 Christos Patriotis, Ph.D., M.Sc.
Brand, Randall

University Of Pittsburgh At Pittsburgh
United States

 Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma 5U01CA200466-08 Matthew Young, Ph.D.
Bresalier, Robert S

University Of Tx Md Anderson Can Ctr
United States

 Great Lakes New England Clinical Validation Center 4U01CA086400-24 Matthew Young, Ph.D.
Chan, Daniel Wanyui

Johns Hopkins University
United States

 BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs 5U2CCA271895-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chinnaiyan, Arul M

University Of Michigan At Ann Arbor
United States

 Michigan-VUMC Biomarker Characterization Center 5U2CCA271854-04 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

 Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus 5U2CCA271902-04 Matthew Young, Ph.D.
Grogan, Eric L

Vanderbilt University Medical Center
United States

 Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer 4U01CA152662-14 Guillermo Marquez, Ph.D.
Hanash, Samir M

University Of Tx Md Anderson Can Ctr
United States

 Clinical Validation Center for Lung Cancer Early Detection 4U01CA271888-04 Guillermo Marquez, Ph.D.
Heine, John J

H. Lee Moffitt Cancer Ctr & Res Inst
United States

 Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center 5U01CA200464-08 Guillermo Marquez, Ph.D.
Herman, James G.

University Of Pittsburgh At Pittsburgh
United States

 Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies 5U2CCA271885-04 Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

 High-throughput immunoproteomics for cancer biomarker discovery 5U2CCA271903-04 Christos Patriotis, Ph.D., M.Sc.
Lenburg, Marc Elliott

Boston University Medical Campus
United States

 The Boston University - UCLA Lung Cancer Biomarker Characterization Center 5U2CCA271898-04 Guillermo Marquez, Ph.D.
Li, Christopher I

Fred Hutchinson Cancer Center
United States

 Fred Hutchinson Breast Cancer Clinical Validation Center 5U01CA152637-15 Sidney Fu, M.D.
Maitra, Anirban

New York University School Of Medicine
United States

 Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D.

News and Events

Prevention and Screening Drive Drop in Cancer Deaths
Date Posted: January 14, 2025

DCP Participation at American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024
Date Posted: March 12, 2024

Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023